OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,973 | +28.7% | 2,427 | -5.9% | 0.00% | – |
| Q2 2023 | $23,297 | +16.5% | 2,580 | -45.7% | 0.00% | – |
| Q1 2022 | $20,000 | -59.2% | 4,749 | -10.4% | 0.00% | – |
| Q4 2021 | $49,000 | -22.2% | 5,299 | +131.2% | 0.00% | – |
| Q3 2021 | $63,000 | +96.9% | 2,292 | +100.7% | 0.00% | – |
| Q2 2021 | $32,000 | -22.0% | 1,142 | -8.3% | 0.00% | – |
| Q1 2021 | $41,000 | – | 1,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $35,043,000 | 3.61% |
| BVF INC/IL | 7,411,503 | $69,372,000 | 2.52% |
| Kynam Capital Management, LP | 293,799 | $2,750,000 | 1.47% |
| Cormorant Asset Management, LP | 2,169,871 | $20,310,000 | 1.21% |
| VR Adviser, LLC | 816,651 | $7,644,000 | 1.04% |
| Vivo Capital, LLC | 1,689,515 | $15,814,000 | 0.95% |
| Octagon Capital Advisors LP | 231,417 | $2,166,000 | 0.42% |
| HighVista Strategies LLC | 50,942 | $477,000 | 0.38% |
| RA Capital Management | 2,150,404 | $20,128,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 500,000 | $4,700,000 | 0.31% |